Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Long-Term Deferred Tax: 2010-2024

Historic Long-Term Deferred Tax for Cross Country Healthcare (CCRN) over the last 8 years, with FY2024 value amounting to $8.1 million.

  • Cross Country Healthcare's Long-Term Deferred Tax rose 466.92% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 466.92%. This contributed to the annual value of $8.1 million for FY2024, which is 3554.11% up from last year.
  • Cross Country Healthcare's Long-Term Deferred Tax amounted to $8.1 million in FY2024, which was up 3554.11% from $6.0 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Long-Term Deferred Tax peaked at $11.5 million during FY2021, and registered a low of $6.0 million during FY2023.
  • Its 4-year average for Long-Term Deferred Tax is $8.2 million, with a median of $7.6 million in 2022.
  • In the last 5 years, Cross Country Healthcare's Long-Term Deferred Tax tumbled by 3824.73% in 2022 and then skyrocketed by 3554.11% in 2024.
  • Over the past 4 years, Cross Country Healthcare's Long-Term Deferred Tax (Annual) stood at $11.5 million in 2021, then plummeted by 38.25% to $7.1 million in 2022, then decreased by 15.99% to $6.0 million in 2023, then surged by 35.54% to $8.1 million in 2024.
  • Its last three reported values are $8.1 million in FY2024, $6.0 million for FY2023, and $7.1 million during FY2022.